A Design-Around Solution for a MMX-Based Tablet Drug Comprising Mesalazine—A Lesson from Shire Development, LLC v. Watson Pharmaceuticals, Inc

Autor:	Ping-Hsun Chen
Rok vydání:	2020
Předmět:	chemistry.chemical_compound Engineering Mesalazine chemistry Watson business.industry Management Monitoring Policy and Law business Shire Biotechnology Management MMX
Zdroj:	Biotechnology Law Report. 39:25-32
ISSN:	1557-8704 0730-031X
DOI:	10.1089/blr.2019.29155.pc
Popis:	This article explores Shire Development, LLC v. Watson Pharmaceuticals, Inc., 848 F.3d 981 (Fed. Cir. 2017) and illustrates some implications for designing around a MMX-based tablet drug, Lialda. T...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::728df82483fd4ac2fd806de978126133 https://doi.org/10.1089/blr.2019.29155.pc Zobrazit plný text záznamu